Inventiva S.A. (EPA:IVA)
3.650
+0.010 (0.27%)
Oct 16, 2025, 12:40 PM CET
Inventiva Revenue
Inventiva had revenue of 5.61M EUR in the half year ending June 30, 2025, a decrease of -15.28%. This brings the company's revenue in the last twelve months to 16.97M, down -10.36% year-over-year. In the year 2024, Inventiva had annual revenue of 14.09M, down -38.24%.
Revenue (ttm)
16.97M
Revenue Growth
-10.36%
P/S Ratio
29.85
Revenue / Employee
202.02K
Employees
118
Market Cap
506.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.09M | -8.73M | -38.24% |
Dec 31, 2023 | 22.82M | 4.77M | 26.41% |
Dec 31, 2022 | 18.05M | 9.55M | 112.35% |
Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |
Inventiva News
- 1 day ago - Inventiva Announces the Implementation of a New ATM Program - GlobeNewsWire
- 6 days ago - Inventiva (IVA) Gets Boosted Price Target from HC Wainwright & Co. | IVA Stock News - GuruFocus
- 7 days ago - Inventiva S.A. (IVA) Analyst/Investor Day - Slideshow - Seeking Alpha
- 7 days ago - Inventiva S.A. (IVA) Analyst/Investor Day Transcript - Seeking Alpha
- 8 days ago - Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025 - GlobeNewsWire
- 15 days ago - Inventiva Names Andrew Obenshain CEO - Nasdaq
- 15 days ago - Inventiva Appoints Andrew Obenshain as Chief Executive Officer - GlobeNewsWire
- 16 days ago - Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga